申请人:Hisamitsu Pharmaceutical Co., Inc.
公开号:US03984415A1
公开(公告)日:1976-10-05
The compounds of the present invention can be represented by the following formula: ##SPC1## Wherein R is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, unsaturated lower alkyl, substituted unsaturated lower alkyl and aralkyl; X is selected from the group consisting of O and S. The compounds of the present invention possess a high degree of pharmacological activities such as anti-inflammatory, anti-ulcerative, analgetic, antipyretic, antihistaminic and central nervous system depressive activities, and certain of them are useful as new anti-inflammatory agents, analgesics and central nervous system depressants.
本发明的化合物可用以下公式表示:##SPC1## 其中R从氢、较低的烷基、取代的较低的烷基、不饱和的较低的烷基、取代的不饱和较低的烷基和芳基中选择;X从O和S中选择。 本发明的化合物具有高度的药理活性,如抗炎、抗溃疡、镇痛、退热、抗组胺和中枢神经系统抑制活性,其中某些化合物可用作新型抗炎药、镇痛剂和中枢神经系统抑制剂。